Supernus Pharmaceuticals Says Targeted in Ransomware Attack | #malware | #ransomware







MT Newswires 2021

All news about SUPERNUS PHARMACEUTICALS, INC.

Sales 2021 568 M

Net income 2021 67,5 M

Net Debt 2021

P/E ratio 2021 25,8x
Yield 2021
Capitalization 1 699 M
1 699 M
Capi. / Sales 2021 2,99x
Capi. / Sales 2022 2,75x
Nbr of Employees 563
Free-Float 95,8%

Chart SUPERNUS PHARMACEUTICALS, INC.

Duration :


Period :



Technical analysis trends SUPERNUS PHARMACEUTICALS, INC.

Short Term Mid-Term Long Term
Trends Bullish Bullish Bullish



Income Statement Evolution

Please enable JavaScript in your browser’s settings to use dynamic charts.

Sell

Buy

Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price
31,94 $
Average target price
34,00 $
Spread / Average Target 6,45%
Please enable JavaScript in your browser’s settings to use dynamic charts.




Original Source link

Posted in Uncategorized

Leave a Reply

Your email address will not be published. Required fields are marked *

8 + = ten